Developer docs
API playgroundTry for free, no card

Search company profiles

Cera

Full company profile

uuid000047r

Namestring
Cera
Legal namestring
Cera Care
Websiteurl
cerahq.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Cera is Europe's largest digital-first home healthcare provider, founded in 2016 and headquartered in London. It operates a regulated home care service (CQC-registered in England with equivalent regulation in Wales and Scotland) delivered by more than 10,000 carers and nurses who complete 2.5 million patient visits per month across 150+ sites in the UK and Germany. Over 100 UK Local Governments and approximately two-thirds of NHS Integrated Care Systems commission Cera, alongside a private-pay channel for individuals and families.

The core platform is the Cera App used by frontline staff at the point of care, layered with proprietary AI tools that include a Falls Prevention AI (predicting 80%+ of falls a week in advance, reducing falls by 20%), a Hospitalisation Predict-Prevent tool (predicting 83%+ of hospitalisations, reducing them by up to 70%), an AI Recruitment Agent ('Ami'), and a January 2026-launched suite of operational agents (Care Coordinator, Field Care Supervisor, Retention). Cera has launched the world's first dedicated AI Lab for the care sector (eight-figure investment) and acquired GenieConnect (Nov 2025) to scale home care robotics. The 300+ billion anonymised patient health data points are being monetised via a life sciences channel through partnerships with Re:Cognition Health, uMed, and Promptly Health for clinical trial access and real-world evidence in over-65s.

The business model combines four revenue streams: (i) commissioned home care services from UK Local Governments and NHS ICSs (subscription/recurring), (ii) private-pay home care for individuals and families, (iii) technology licensing of AI agents, AI tools, and care robots to third-party providers, and (iv) data and research partnerships with pharmaceutical and biotech customers. Cera scaled from $5M to ~$500M annualised revenue in five years, achieved EBITDA-positive status in 2023 and free cash flow positivity in 2024, and raised a $150M round in January 2025 (BDT & MSD Partners and Schroders Capital) at unicorn valuation, taking cumulative funding to ~$479M (~$600M). Strategic differentiators include public sector relationships, scaled proprietary data, regulatory compliance, and expansion into adjacent revenue streams via AI Lab licensing.

Short descriptiontext

Cera is Europe's largest digital-first home healthcare provider, delivering AI-enabled home care via 10,000+ carers and nurses across 150+ UK sites and Germany to over 100 Local Governments, nearly two-thirds of NHS Integrated Care Systems, and private-pay families.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home healthcare services, AI-powered care platform, predictive health analytics, domiciliary care services, care workforce technology
Industry3 codes
PRIMARYHLADAGAI
Live-In & 24/7 In-Home Care
Healthcare & Life Sciences/Elder Care & Long-Term Care/Non-Medical In-Home Care & Personal Care
SECONDARYHLADABAB
Assisted Living with Memory Care (Mixed Campus)
SECONDARYHSABAEAB
Dementia Personal Care (ADLs) Support
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care
NAICS code3 codes
  • Home Health Care Services62161
  • Services for the Elderly and Persons with Disabilities624120
  • Other Residential Care Facilities62399
SIC code3 codes
  • Services-Home Health Care Services8082
  • Services-Nursing & Personal Care Facilities8050
  • Services-Skilled Nursing Care Facilities8051
Product category
Home Healthcare Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model7 records
1Home Healthcare Services (Public Sector)
TypeSubscription Recurring
Description

Cera provides home healthcare services commissioned by UK Local Governments and NHS Integrated Care Systems. This is the core revenue stream, with over 100 Local Governments and nearly two-thirds of NHS Integrated Care Systems as clients. Care services include domiciliary care, reablement, complex care, supported living, and nursing care.

cerahq.com
2Private Pay Home Care Services
TypeSubscription Recurring
Description

Cera offers private care services to individuals and families, with care plans personalised to the service user's needs, delivered by expertly trained carers and nurses. Available in as little as 48 hours.

cerahq.com
3Non-Home Care Service Lines
TypeLicensing Royalties
Description

Cera has expanded beyond core domiciliary care into service lines including specialist nurse-led care, complex care, supported living, learning disabilities care, home care robotics, and AI tool licensing. These non-home care service lines have surpassed US$100m in annualised revenues, representing one-fifth of the overall ~$500m business.

linkedin.com
4AI Agent Licensing
TypeLicensing Royalties
Description

Cera licenses its AI agents (Ami recruitment agent, AI Care Coordinator, Field Care Supervisor Agent, Retention Agent) to other health and care organisations. Licensing agreements extend Cera's technology reach beyond its own operations.

cerahq.com
5Care Robotics Licensing
TypeHardware Sales
Description

Following the acquisition of GenieConnect and an exclusive deal with the robot manufacturer, Cera licenses home care robots to other care providers. GenieConnect claims to reduce cost of care by £3,700+ per person annually.

healthcareleadernews.com
6Healthcare Research and Clinical Trial Partnerships
TypeData Monetisation
Description

Cera partners with NHS, academic institutions, and life sciences companies to support clinical trials and real-world evidence studies for over-65s. Draws on its dataset to identify eligible patients, potentially generating revenue through research partnerships with pharmaceutical and biotech companies.

cerahq.com
7Acquisitions of Care Businesses
TypeManaged Services
Description

Cera acquires care businesses as part of its growth strategy, with several transactions completed since 2018. The acquisitions team acquires domiciliary care, complex care, and specialist care providers across the UK and Germany.

cerahq.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Private home care — personalised care plans for individuals and families
ModelSubscriptionBilling cadenceMonthly
Notes

Care plans are personalised to individual needs. Cera offers flexible, drop-in visits from 30 minutes to several hours per day, as well as live-in care options. Care available in as little as 48 hours. Pricing is arranged on enquiry through the company's campaign/enquiry system — not publicly disclosed on the website.

cerahq.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Cera delivers digital-first home healthcare services across the UK, employing 10,000+ carers and nurses who conduct 2.5 million home visits per month. The company provides elderly care, nursing and complex care, live-in care, supported living, extra care, and learning disability services directly to service users in their homes, while licensing its proprietary AI platform (predictive fall/hospitalisation prevention, autonomous AI agents, care robots) to other care providers. Core revenue is generated from public sector commissioning by over 100 UK Local Governments and nearly two-thirds of NHS Integrated Care Systems, with secondary revenue from private pay care subscriptions to individuals and families.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • 100 million patient home visits delivered since 2016, with 2.5 million visits per month at one visit every second on average
+12 more records
Product overview1 text field

Cera is Europe's largest HealthTech company providing digital-first home healthcare. The company's platform centers on the Cera App, used by 10,000 carers and nurses to deliver 2.5 million home visits monthly. Built on a dataset of over 300 billion anonymized patient health insights, the platform integrates AI-powered predictive tools (Falls Prevention AI, Hospitalisation Predict-Prevent Tool), autonomous AI agents (Recruitment Agent Ami, AI Care Coordinator, Field Care Supervisor, AI Retention Agent), care robotics (GenieConnect), family monitoring (Family App), and AI Training Avatars. The company operates an AI Lab for sector-wide innovation and licenses its technology to other care providers.

Product and service5 records
1Home Healthcare Services (Domiciliary, Reablement, Complex, Live-in, Supported Living, Extra Care, Learning Disabilities)
CategoryHome Healthcare Services
Description

Core in-home care services delivered by 10,000+ carers and nurses: Elderly Care at Home (personal care, medication, companionship, meal preparation); Nursing & Complex Care (wound care, PEG feeds, stoma care, oxygen support); Live-in Care; Supported Living; Extra Care; and Learning Disabilities care. Commissioned by UK Local Governments and NHS Integrated Care Systems, and available to self-paying individuals and families. Services delivered at 2.5 million home visits per month across 150+ regulated UK sites.

2Cera AI Lab
CategoryAI Research & Licensing
Description

World's first dedicated AI research laboratory for the care sector, established with an eight-figure investment. Develops, tests, and licenses AI tools for care providers in the UK and overseas. Leverages Cera's proprietary dataset of over 300 billion anonymised patient health insights.

3AI Recruitment Agent 'Ami'
CategoryAI Workforce Software (Licensing)
Description

Standalone AI-powered autonomous recruitment agent conducting five-minute screening telephone interviews, scoring candidates on attitude and experience, and booking qualified applicants for human recruiter interviews. Licensed to other health and care organisations.

4AI Care Agent Suite (Care Coordinator, Field Care Supervisor, Retention)
CategoryAI Workforce Software (Licensing)
Description

Suite of three autonomous AI agents licensed to other care providers: AI Care Coordinator (halves staff cover scheduling time), Field Care Supervisor Agent (85% reduction in quality review time), and AI Retention Agent (up to 22% improvement in retention by contacting at-risk carers 7x faster than humans).

5GenieConnect Home Care Robots
CategoryCare Robotics (Hardware & Software)
Description

AI-driven home care robotics platform providing medication reminders, hydration prompts, social connection tools, and remote monitoring. Acquired by Cera and licensed to other care providers. Generates over 3,000 virtual visits per week.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Cera announced a UK government-backed training initiative offering 2-6 week programmes to young adults aged 18-24 and individuals over 50, with guaranteed job interviews upon completion for care assistant positions. Fifty Sector-Based Work Academy Programmes are planned, each accommodating up to 15 participants, with successful completers receiving a level one qualification in health and social care. This initiative aims to address rising youth unemployment and a shortage of care workers, with adult social care facing an estimated 111,000 vacancies in England in 2024/25.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Partnership to improve access to Alzheimer's disease and neurodegenerative clinical trials by linking home care with specialist research centres. The collaboration aims to facilitate early referral, assessment, and trial participation for patients, especially those difficult to reach through traditional clinic-based methods.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-01
Description

Partnership bringing clinical research directly to homes of those who need access to innovative treatments, using uMed's automated living registry platform to identify and engage eligible patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-01
Description

Cera acquired the GenieConnect care robotics platform and secured an exclusive deal with the robot manufacturer to scale home care robots across the UK. GenieConnect reduces the cost of care by £3,700 or more per person annually. Cera is licensing robots to other care providers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Cera joined Promptly Health's European network to give Life Sciences companies access to real-world evidence needed for medicine approvals, supporting geriatric drug development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

Coalition partner in Cera's Back to Work initiative to recruit unemployed and economically inactive adults into care roles. Skills for Care is the strategic voice for adult social care workforce development in England. Cera set a target of 10% of new recruits from economic inactivity.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Back to Work recruitment partner that matched job seekers including double amputee Mark to care roles at Cera. Maximus provides job coaching and employment support services.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Back to Work coalition partner providing employment support and training programmes to help economically inactive adults enter the care workforce.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Back to Work coalition partner helping people rebuild their careers after major life challenges, as part of Cera's initiative to get Britain back to work.

10Government Schemes (Restart, Work and Health Programme)
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Cera's Back to Work coalition partners with UK Government employment schemes including Restart and the Work and Health Programme to identify and recruit long-term unemployed and economically inactive adults into care roles.

cerahq.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

The UK Government has endorsed Cera's AI Lab as a model for NHS transformation that can be exported globally. Government ministers including the Health and Social Care Secretary have highlighted Cera as an example of needed change in healthcare. Cera works with over 100 UK Local Governments and NHS ICSs commissioned by public bodies.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global home care franchise with a strong UK presence delivering personal care, dementia care, and live-in care to elderly clients. Direct peer to Cera in the UK home care market with similar customer segments and service mix, though a less tech-enabled operating model.

TypeDirect peer
Description

UK-based specialist in live-in and visiting home care, focused on elderly and complex care needs. Directly comparable to Cera's live-in and domiciliary care services, with overlapping geographic coverage and customer profiles.

3BAYADA Home Health Care
TypeBroad incumbent
Description

One of the largest US non-profit home health providers offering skilled nursing, therapy, and personal care services at scale. Comparable to Cera in service breadth and scale ambition, with analogous focus on complex care and clinical outcomes.

TypeDirect peer
Description

UK home care franchise providing visiting and live-in care to elderly and vulnerable clients. Direct peer in the UK private-pay and local-authority commissioned home care market with a similar service portfolio, though at a smaller scale than Cera.

5Bluebird Care
TypeDirect peer
Description

UK home care franchise network providing personal care, dementia support, and complex care in customers' homes. Comparable to Cera's UK-wide footprint and core service lines, serving both private-pay and publicly commissioned customers.

TypeEmerging player
Description

US-based technology-enabled home care platform combining software with care delivery networks. Closest international analogue to Cera's digital-first home care model, with similar focus on workforce technology and predictive analytics, though operating in the US market.

TypeBroad incumbent
Description

Largest operator of residential care homes in the UK, serving elderly residents with personal and nursing care. Broad incumbent in the same UK care sector as Cera but focused on residential rather than domiciliary delivery, with significant NHS/Local Authority relationships.

TypeRegional player
Description

Large US-based home health and hospice provider focused on skilled nursing and rehabilitation at home. Comparable to Cera in home health services and clinical focus, but operating in the US regulatory and reimbursement environment rather than the UK.

TypeOthers
Description

Canada-based software platform providing home care management, scheduling, and clinical documentation tools to care providers globally. Adjacent to Cera as a technology enabler for home care, but operates as a vendor rather than a care provider.

TypeOthers
Description

US healthcare technology company providing software and analytics solutions across the continuum of care, including home health. Indirect competitor to Cera's AI tooling business and adjacent technology provider for the broader home care market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cera

Home Healthcare Servicescerahq.com

Cera is Europe's largest digital-first home healthcare provider, delivering AI-enabled home care via 10,000+ carers and nurses across 150+ UK sites and Germany to over 100 Local Governments, nearly two-thirds of NHS Integrated Care Systems, and private-pay families.

What Cera does

Cera is Europe's largest digital-first home healthcare provider, founded in 2016 and headquartered in London. It operates a regulated home care service (CQC-registered in England with equivalent regulation in Wales and Scotland) delivered by more than 10,000 carers and nurses who complete 2.5 million patient visits per month across 150+ sites in the UK and Germany. Over 100 UK Local Governments and approximately two-thirds of NHS Integrated Care Systems commission Cera, alongside a private-pay channel for individuals and families.

The core platform is the Cera App used by frontline staff at the point of care, layered with proprietary AI tools that include a Falls Prevention AI (predicting 80%+ of falls a week in advance, reducing falls by 20%), a Hospitalisation Predict-Prevent tool (predicting 83%+ of hospitalisations, reducing them by up to 70%), an AI Recruitment Agent ('Ami'), and a January 2026-launched suite of operational agents (Care Coordinator, Field Care Supervisor, Retention). Cera has launched the world's first dedicated AI Lab for the care sector (eight-figure investment) and acquired GenieConnect (Nov 2025) to scale home care robotics. The 300+ billion anonymised patient health data points are being monetised via a life sciences channel through partnerships with Re:Cognition Health, uMed, and Promptly Health for clinical trial access and real-world evidence in over-65s.

The business model combines four revenue streams: (i) commissioned home care services from UK Local Governments and NHS ICSs (subscription/recurring), (ii) private-pay home care for individuals and families, (iii) technology licensing of AI agents, AI tools, and care robots to third-party providers, and (iv) data and research partnerships with pharmaceutical and biotech customers. Cera scaled from $5M to ~$500M annualised revenue in five years, achieved EBITDA-positive status in 2023 and free cash flow positivity in 2024, and raised a $150M round in January 2025 (BDT & MSD Partners and Schroders Capital) at unicorn valuation, taking cumulative funding to ~$479M (~$600M). Strategic differentiators include public sector relationships, scaled proprietary data, regulatory compliance, and expansion into adjacent revenue streams via AI Lab licensing.

Cera firmographics

Firmographics
Name
Cera
Legal name
Cera Care
Website
https://cerahq.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Cera is Europe's largest digital-first home healthcare provider, delivering AI-enabled home care via 10,000+ carers and nurses across 150+ UK sites and Germany to over 100 Local Governments, nearly two-thirds of NHS Integrated Care Systems, and private-pay families.
Ownership category
akta.pro rank

Cera industry classification

Industry
Product category
Home Healthcare Services
NAICS
Home Health Care Services (62161), Services for the Elderly and Persons with Disabilities (624120), Other Residential Care Facilities (62399)
SIC
Services-Home Health Care Services (8082), Services-Nursing & Personal Care Facilities (8050), Services-Skilled Nursing Care Facilities (8051)
akta.pro industry
PRIMARYHLADAGAI
Live-In & 24/7 In-Home Care
Healthcare & Life Sciences/Elder Care & Long-Term Care/Non-Medical In-Home Care & Personal Care
SECONDARYHLADABAB
Assisted Living with Memory Care (Mixed Campus)
SECONDARYHSABAEAB
Dementia Personal Care (ADLs) Support
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care

Keywords

  • Home healthcare services
  • AI-powered care platform
  • Predictive health analytics
  • Domiciliary care services
  • Care workforce technology

Where Cera is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Cera business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Home Healthcare Services (Public Sector): Cera provides home healthcare services commissioned by UK Local Governments and NHS Integrated Care Systems. This is the core revenue stream, with over 100 Local Governments and nearly two-thirds of NHS Integrated Care Systems as clients. Care services include domiciliary care, reablement, complex care, supported living, and nursing care.
  2. Private Pay Home Care Services: Cera offers private care services to individuals and families, with care plans personalised to the service user's needs, delivered by expertly trained carers and nurses. Available in as little as 48 hours.
  3. Non-Home Care Service Lines: Cera has expanded beyond core domiciliary care into service lines including specialist nurse-led care, complex care, supported living, learning disabilities care, home care robotics, and AI tool licensing. These non-home care service lines have surpassed US$100m in annualised revenues, representing one-fifth of the overall ~$500m business.
  4. AI Agent Licensing: Cera licenses its AI agents (Ami recruitment agent, AI Care Coordinator, Field Care Supervisor Agent, Retention Agent) to other health and care organisations. Licensing agreements extend Cera's technology reach beyond its own operations.
  5. Care Robotics Licensing: Following the acquisition of GenieConnect and an exclusive deal with the robot manufacturer, Cera licenses home care robots to other care providers. GenieConnect claims to reduce cost of care by £3,700+ per person annually.
  6. Healthcare Research and Clinical Trial Partnerships: Cera partners with NHS, academic institutions, and life sciences companies to support clinical trials and real-world evidence studies for over-65s. Draws on its dataset to identify eligible patients, potentially generating revenue through research partnerships with pharmaceutical and biotech companies.
  7. Acquisitions of Care Businesses: Cera acquires care businesses as part of its growth strategy, with several transactions completed since 2018. The acquisitions team acquires domiciliary care, complex care, and specialist care providers across the UK and Germany.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyPrivate home care — personalised care plans for individuals and families

Go-to-market motion3 records

Distribution channels7 records

Marketing channels9 records

Cera product offering

Product offering

Core offering

Cera delivers digital-first home healthcare services across the UK, employing 10,000+ carers and nurses who conduct 2.5 million home visits per month. The company provides elderly care, nursing and complex care, live-in care, supported living, extra care, and learning disability services directly to service users in their homes, while licensing its proprietary AI platform (predictive fall/hospitalisation prevention, autonomous AI agents, care robots) to other care providers. Core revenue is generated from public sector commissioning by over 100 UK Local Governments and nearly two-thirds of NHS Integrated Care Systems, with secondary revenue from private pay care subscriptions to individuals and families.

Product overview

Cera is Europe's largest HealthTech company providing digital-first home healthcare. The company's platform centers on the Cera App, used by 10,000 carers and nurses to deliver 2.5 million home visits monthly. Built on a dataset of over 300 billion anonymized patient health insights, the platform integrates AI-powered predictive tools (Falls Prevention AI, Hospitalisation Predict-Prevent Tool), autonomous AI agents (Recruitment Agent Ami, AI Care Coordinator, Field Care Supervisor, AI Retention Agent), care robotics (GenieConnect), family monitoring (Family App), and AI Training Avatars. The company operates an AI Lab for sector-wide innovation and licenses its technology to other care providers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Home Healthcare Services (Domiciliary, Reablement, Complex, Live-in, Supported Living, Extra Care, Learning Disabilities) Core in-home care services delivered by 10,000+ carers and nurses: Elderly Care at Home (personal care, medication, companionship, meal preparation); Nursing & Complex Care (wound care, PEG feeds, stoma care, oxygen support); Live-in Care; Supported Living; Extra Care; and Learning Disabilities care. Commissioned by UK Local Governments and NHS Integrated Care Systems, and available to self-paying individuals and families. Services delivered at 2.5 million home visits per month across 150+ regulated UK sites.
  • Cera AI Lab World's first dedicated AI research laboratory for the care sector, established with an eight-figure investment. Develops, tests, and licenses AI tools for care providers in the UK and overseas. Leverages Cera's proprietary dataset of over 300 billion anonymised patient health insights.
  • AI Recruitment Agent 'Ami' Standalone AI-powered autonomous recruitment agent conducting five-minute screening telephone interviews, scoring candidates on attitude and experience, and booking qualified applicants for human recruiter interviews. Licensed to other health and care organisations.
  • AI Care Agent Suite (Care Coordinator, Field Care Supervisor, Retention) Suite of three autonomous AI agents licensed to other care providers: AI Care Coordinator (halves staff cover scheduling time), Field Care Supervisor Agent (85% reduction in quality review time), and AI Retention Agent (up to 22% improvement in retention by contacting at-risk carers 7x faster than humans).
  • GenieConnect Home Care Robots AI-driven home care robotics platform providing medication reminders, hydration prompts, social connection tools, and remote monitoring. Acquired by Cera and licensed to other care providers. Generates over 3,000 virtual visits per week.

Quantifiable outcome

  • 100 million patient home visits delivered since 2016, with 2.5 million visits per month at one visit every second on average
  • +12 more outcomes

Companies that use Cera

Customer profile

Named customers7 records

Segments7 records

Ideal customer profiles5 records

Cera technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature12 records

Cera partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • UK Government (Department for Work and Pensions)coreStrategic or Co-development Partner · 1 June 2026Cera announced a UK government-backed training initiative offering 2-6 week programmes to young adults aged 18-24 and individuals over 50, with guaranteed job interviews upon completion for care assistant positions. Fifty Sector-Based Work Academy Programmes are planned, each accommodating up to 15 participants, with successful completers receiving a level one qualification in health and social care. This initiative aims to address rising youth unemployment and a shortage of care workers, with adult social care facing an estimated 111,000 vacancies in England in 2024/25.
  • Re:Cognition HealthcoreStrategic or Co-development Partner · 1 February 2026Partnership to improve access to Alzheimer's disease and neurodegenerative clinical trials by linking home care with specialist research centres. The collaboration aims to facilitate early referral, assessment, and trial participation for patients, especially those difficult to reach through traditional clinic-based methods.
  • uMedcoreStrategic or Co-development Partner · 1 November 2025Partnership bringing clinical research directly to homes of those who need access to innovative treatments, using uMed's automated living registry platform to identify and engage eligible patients.
  • GenieConnect (Acquisition)coreStrategic or Co-development Partner · 1 November 2025Cera acquired the GenieConnect care robotics platform and secured an exclusive deal with the robot manufacturer to scale home care robots across the UK. GenieConnect reduces the cost of care by £3,700 or more per person annually. Cera is licensing robots to other care providers.
  • Promptly HealthcoreStrategic or Co-development Partner · 1 October 2025Cera joined Promptly Health's European network to give Life Sciences companies access to real-world evidence needed for medicine approvals, supporting geriatric drug development.
  • Skills for CarecoreStrategic or Co-development Partner · 1 October 2024Coalition partner in Cera's Back to Work initiative to recruit unemployed and economically inactive adults into care roles. Skills for Care is the strategic voice for adult social care workforce development in England. Cera set a target of 10% of new recruits from economic inactivity.
  • MaximusminorChannel Partner/ Reseller/ Distributor · 1 October 2024Back to Work recruitment partner that matched job seekers including double amputee Mark to care roles at Cera. Maximus provides job coaching and employment support services.
  • People PlusminorChannel Partner/ Reseller/ Distributor · 1 October 2024Back to Work coalition partner providing employment support and training programmes to help economically inactive adults enter the care workforce.
  • BeamminorChannel Partner/ Reseller/ Distributor · 1 October 2024Back to Work coalition partner helping people rebuild their careers after major life challenges, as part of Cera's initiative to get Britain back to work.
  • Government Schemes (Restart, Work and Health Programme)minorChannel Partner/ Reseller/ Distributor · 1 October 2024Cera's Back to Work coalition partners with UK Government employment schemes including Restart and the Work and Health Programme to identify and recruit long-term unemployed and economically inactive adults into care roles.
  • UK GovernmentcoreGTM or Marketing PartnerThe UK Government has endorsed Cera's AI Lab as a model for NHS transformation that can be exported globally. Government ministers including the Health and Social Care Secretary have highlighted Cera as an example of needed change in healthcare. Cera works with over 100 UK Local Governments and NHS ICSs commissioned by public bodies.

Scale indicators12 records

Recent moves9 records

Expansion highlights8 records

Cera competitors and assessment

Company assessment

Direct peers

  • Home Instead: Global home care franchise with a strong UK presence delivering personal care, dementia care, and live-in care to elderly clients. Direct peer to Cera in the UK home care market with similar customer segments and service mix, though a less tech-enabled operating model.
  • Helping Hands Home Care: UK-based specialist in live-in and visiting home care, focused on elderly and complex care needs. Directly comparable to Cera's live-in and domiciliary care services, with overlapping geographic coverage and customer profiles.
  • GoodOaks Homecare: UK home care franchise providing visiting and live-in care to elderly and vulnerable clients. Direct peer in the UK private-pay and local-authority commissioned home care market with a similar service portfolio, though at a smaller scale than Cera.
  • Bluebird Care: UK home care franchise network providing personal care, dementia support, and complex care in customers' homes. Comparable to Cera's UK-wide footprint and core service lines, serving both private-pay and publicly commissioned customers.

Broad incumbents

  • BAYADA Home Health Care: One of the largest US non-profit home health providers offering skilled nursing, therapy, and personal care services at scale. Comparable to Cera in service breadth and scale ambition, with analogous focus on complex care and clinical outcomes.
  • HC-One: Largest operator of residential care homes in the UK, serving elderly residents with personal and nursing care. Broad incumbent in the same UK care sector as Cera but focused on residential rather than domiciliary delivery, with significant NHS/Local Authority relationships.

Emerging players

  • Honor Technology: US-based technology-enabled home care platform combining software with care delivery networks. Closest international analogue to Cera's digital-first home care model, with similar focus on workforce technology and predictive analytics, though operating in the US market.

Regional players

  • Amedisys: Large US-based home health and hospice provider focused on skilled nursing and rehabilitation at home. Comparable to Cera in home health services and clinical focus, but operating in the US regulatory and reimbursement environment rather than the UK.

Others

  • AlayaCare: Canada-based software platform providing home care management, scheduling, and clinical documentation tools to care providers globally. Adjacent to Cera as a technology enabler for home care, but operates as a vendor rather than a care provider.
  • WellSky: US healthcare technology company providing software and analytics solutions across the continuum of care, including home health. Indirect competitor to Cera's AI tooling business and adjacent technology provider for the broader home care market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cera social profiles

Digital presence

Cera compliance and trust

Trust signal

Compliance7 records

Cera financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cera leadership team

Management profile

Number of profiles

Profiles7 records

Cera subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cera funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cera M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cera

What does Cera do?

Cera delivers digital-first home healthcare services across the UK, employing 10,000+ carers and nurses who conduct 2.5 million home visits per month. The company provides elderly care, nursing and complex care, live-in care, supported living, extra care, and learning disability services directly to service users in their homes, while licensing its proprietary AI platform (predictive fall/hospitalisation prevention, autonomous AI agents, care robots) to other care providers. Core revenue is generated from public sector commissioning by over 100 UK Local Governments and nearly two-thirds of NHS Integrated Care Systems, with secondary revenue from private pay care subscriptions to individuals and families.

Is Cera a public or private company?

Cera is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cera founded?

Cera was founded in 2016. It employs 5,001 to 10,000 people.

Where is Cera based?

Cera is headquartered in London, United Kingdom, in the Europe region.

How does Cera make money?

Seven revenue lines are on record. Home Healthcare Services (Public Sector) is the primary driver. The others are private Pay Home Care Services, non-Home Care Service Lines, AI Agent Licensing, care Robotics Licensing, healthcare Research and Clinical Trial Partnerships and acquisitions of Care Businesses.

Who are Cera's main competitors?

Direct peers on record are Home Instead, Helping Hands Home Care, GoodOaks Homecare and Bluebird Care. Broad incumbents are BAYADA Home Health Care and HC-One. Honor Technology is listed as an emerging player. Amedisys is listed as a regional player. Others are AlayaCare and WellSky.

Does Cera have an API?

No public API is recorded for Cera.

What industry is Cera in?

Cera's product category is Home Healthcare Services. Its primary akta.pro industry code is HLADAGAI, Live-In & 24/7 In-Home Care, with a secondary code of HLADABAB, Assisted Living with Memory Care (Mixed Campus). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BusinessCloudCera scoops major health tech award as it turns 10Cera, a London-based AI-powered home healthcare company, won Health Tech Company of the Year at the Health Tech World Awards 2026, celebrating its 10th anniversary. The company delivers about 100,000 home visits daily and has saved the NHS and government over £1bn to date.BBCMeet Robert the robot looking after Vera, 74, in her own homeVera, 74, lives at a Lewisham retirement home with a Cera robot named Robert that reminds her of medication and offers companionship. Cera claims its robots reduce hospital admissions by up to 70% and boost care team capacity by 20%. The article questions whether residents prefer robot company over human connection.BBCMeet Robert the robot looking after Vera, 74, in her own homeVera Gadsdon, 74, at a Lewisham retirement home uses a Cera robot named Robert for medication reminders and companionship. Cera claims its AI tools reduce hospital admissions by up to 70% and boost care team capacity by 20%. The company says at least 1,000 people across England use the robots.Scotland NewsThe future of elderly care may already be hereAI-enabled robots are already used in UK homes for medication reminders and companionship, with Cera acquiring GenieConnect to expand adoption. Cera says its robots boost care capacity by 20% and save up to £11,500 per patient annually. Wider rollout is planned over 18 months.ObserverArmy of robot ‘nandroids’ join Burnham’s planned revoluti...Cera, a UK tech healthcare company, has deployed AI-enabled 'Genie' robots in social care settings across 14 local authorities to assist elderly residents with medication reminders and daily tasks. The implementation has reportedly boosted care capacity by 20%, improved productivity by 80%, and saved councils approximately £11,500 per patient annually while reducing hospital admissions.BusinessCloudFounder 250: Meet the health and beauty foundersForty-one of BusinessCloud's Founder 250 list work in health and beauty, covering skincare, supplements, and digital clinics. Notable names include REFY Beauty, Tropic Skincare, and Cera, with some companies reaching £40m to $100m in revenue. The list highlights founder-led businesses with significant UK presence.The IndependentYoung adults and over-50s offered training in care system in new bid to ‘get Britain working’Healthcare provider Cera has announced a UK government-backed training initiative offering 2-6 week programmes to young adults aged 18-24 and individuals over 50, with guaranteed job interviews upon completion for care assistant positions. Fifty Sector-Based Work Academy Programmes are planned, each accommodating up to 15 participants, with successful completers receiving a level one qualification in health and social care. The initiative aims to address rising youth unemployment and a shortage of care workers, with the adult social care sector facing an estimated 111,000 vacancies in England in 2024/25.Health Tech WorldCera signs up one new local government every week for fastest ever care robot rolloutCera announced it will sign one new local government weekly to roll out care robots in UK home care. Pilots show 96% success for medication reminders and 64-80% for eating, with annual savings over £11,500 per patient. The rollout expands care capacity by 20% and productivity by up to 80%.Healthcare TodayInnovation in healthcare roundup: Doctor Care Anywhere, Cera, Semble, CocoonThis UK healthcare innovation roundup covers six separate announcements: Doctor Care Anywhere partnered with Tandem Health to integrate ambient voice AI that automates clinical documentation, reportedly saving clinicians up to 40% of their time; Teesside-based Micropore Technologies launched HORIZON, a next-generation emulsification platform designed to accelerate the scale-up of complex drug formulations from lab to commercial production; and Cera, the UK's largest domiciliary care provider, established the world's first dedicated AI lab for the care sector with an eight-figure investment, leveraging its dataset of over 300 billion health insights. Additional developments include Semble's CQC Companion toolkit to help private healthcare providers navigate inspections, Cocoon's launch of a preventative healthcare clinic in Yorkshire, and Contura Orthopaedics' white paper on Arthrosamid, an injectable hydrogel that could offer a non-surgical alternative for knee osteoarthritis patients.ItbriefCera launches AI Lab with eight-figure care investmentLondon-based health technology company Cera has launched an AI Lab to develop, test and license artificial intelligence tools for care providers in the UK and overseas, backed by an eight-figure investment. The lab will leverage a dataset of over 300 billion anonymised patient health insights gathered through 2.5 million monthly home visits by carers and nurses. The UK Government has endorsed the launch, positioning it as a model for NHS transformation that can be exported globally to address workforce shortages and rising demand for care services.